Literature DB >> 4983351

A study of the behavior of propionyl erythromycin in blood by a new chromatographic method.

V C Stephens, C T Pugh, N E Davis, M M Hoehn, S Ralston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4983351     DOI: 10.7164/antibiotics.22.551

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  7 in total

1.  Single-dose fasting bioequivalence assessment of erythromycin stearate tablets in man.

Authors:  G J Yakatan; W J Poynor; R G Harris; A Martin; R G Leonard; A H Briggs; J T Doluisio
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

2.  Plasma and salivary concentrations of erythromycin after administration of three different formulations.

Authors:  J Henry; P Turner; M Garland; F Esmieu
Journal:  Postgrad Med J       Date:  1980-10       Impact factor: 2.401

3.  Paper chromatographic techniques for the determination of cephalothin and desacetylcephalothin in body fluids.

Authors:  M M Hoehn; H W Murphy; C T Pugh; N E Davis
Journal:  Appl Microbiol       Date:  1970-11

4.  Studies on the absorption, distribution, metabolism, and excretion of propionylmaridomycin in rats.

Authors:  T Matsuzawa; T Kondo; Y Kita
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

5.  Factors determining the passage of drugs from blood into saliva.

Authors:  K W Stephen; J McCrossan; D Mackenzie; C B Macfarlane; C F Speirs
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

6.  Therapeutic doses of erythromycin esteolate is not cholestatic in rats in vivo.

Authors:  I Fiebiger; M S Anwer; D Hegner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

7.  The influence of food on the bioavailability of new formulations of erythromycin stearate and base.

Authors:  J Rutland; N Berend; G E Marlin
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.